EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Src inhibition modulates AMBRA1 ‐mediated mitophagy to counteract endothelial‐to‐mesenchymal transition in renal allograft fibrosis

Zeping Gui iD, Xuzhong Liu, Zhen Xu, Dengyuan Feng, Zhou Hang, Ming Zheng, Hao Chen, Shuang Fei, Li Sun, Jun Tao, Zhijian Han, Xiaobin Ju und 3 weitere

Cell Proliferation · 2024

DOI: 10.1111/cpr.13699 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Proliferation, 2024. Verfasst von Zeping Gui und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Second Affiliated Hospital with Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Mitophagy, Fibrosis, Kidney Transplantation, src-Family Kinases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jiangsu Province Natural Science Foundation Program, "333 High Level Talents Project" in Jiangsu Province, Xuzhou Medical University Outstanding Talents Fund Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic allograft dysfunction (CAD) poses a significant challenge in kidney transplantation, with renal vascular endothelial‐to‐mesenchymal transition (EndMT) playing a vital role. While renal vascular EndMT has been verified as an important contributing factor to renal allograft interstitial fibrosis/tubular atrophy in CAD patients, its underlying mechanisms remain obscure. Currently, Src activation is closely linked to organ fibrosis development. Single‐cell transcriptomic analysis in clinical patients revealed that Src is a potential pivotal mediator in CAD progression. Our findings revealed a significant upregulation of Src which closely associated with EndMT in CAD patients, allogeneic kidney transplanted rats and endothelial cells lines. In vivo, Src inhibition remarkably alleviate EndMT and renal allograft interstitial fibrosis in allogeneic kidney transplanted rats. It also had a similar antifibrotic effect in two endothelial cell lines. Mechanistically, the knockout of Src resulted in an augmented AMBRA1‐mediated mitophagy in endothelial cells. We demonstrate that Src knockdown upregulates AMBRA1 level and activates mitophagy by stabilizing Parkin's ubiquitination levels and mitochondrial translocation. Subsequent experiments demonstrated that the knockdown of the Parkin gene inhibited mitophagy in endothelial cells, leading to increased production of Interleukin‐6, thereby inducing EndMT. Consequently, our study underscores Src as a critical mediator of renal vascular EndMT and allograft interstitial fibrosis, exerting its impact through the regulation of AMBRA1/Parkin‐mediated mitophagy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitophagyFibrosisKidney Transplantationsrc-Family KinasesAnimalsRatsHumansMaleAdaptor Proteins, Signal TransducingAllograftsKidneyEpithelial-Mesenchymal TransitionUbiquitin-Protein LigasesEndothelial Cells

Substanzen

src-Family KinasesAdaptor Proteins, Signal TransducingUbiquitin-Protein Ligasesparkin protein

Autor:innen und Institutionen

  • Department of Urology, The Second Affiliated Hospital with Nanjing Medical University, Nanjing, China.
  • Department of Urology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
  • Department of Urology, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, China.
  • Department of Urology, Affiliated Clinical College of Xuzhou Medical University, Huai'an, China.
  • Department of Urology, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, China.

ORCID-Profile: Zeping Gui

Förderung

  • Jiangsu Province Natural Science Foundation Program
  • "333 High Level Talents Project" in Jiangsu Province
  • Xuzhou Medical University Outstanding Talents Fund Project
  • Huaian First People's Hospital High-level Talent Project
  • National Natural Science Foundation of China
  • Postgraduate Research & Practice Innovation Program of Jiangsu Province

Zitieren

APA

Gui, Z., Liu, X., Xu, Z., Feng, D., Hang, Z., Zheng, M., Chen, H., Fei, S., Sun, L., Tao, J., Han, Z., Ju, X., Gu, M., Tan, R., & Wang, Z. (2024). Src inhibition modulates AMBRA1 ‐mediated mitophagy to counteract endothelial‐to‐mesenchymal transition in renal allograft fibrosis. Cell Proliferation. https://doi.org/10.1111/cpr.13699

Vancouver

Gui Z, Liu X, Xu Z, Feng D, Hang Z, Zheng M, et al. Src inhibition modulates AMBRA1 ‐mediated mitophagy to counteract endothelial‐to‐mesenchymal transition in renal allograft fibrosis. Cell Proliferation. 2024. doi:10.1111/cpr.13699

BibTeX
@article{Gui2024,
  author = {Gui, Zeping and Liu, Xuzhong and Xu, Zhen and Feng, Dengyuan and Hang, Zhou and Zheng, Ming and Chen, Hao and Fei, Shuang and Sun, Li and Tao, Jun and Han, Zhijian and Ju, Xiaobin and Gu, Min and Tan, Ruoyun and Wang, Zijie},
  title = {Src inhibition modulates AMBRA1 ‐mediated mitophagy to counteract endothelial‐to‐mesenchymal transition in renal allograft fibrosis},
  journal = {Cell Proliferation},
  year = {2024},
  doi = {10.1111/cpr.13699}
}
Kostenlos starten →